Jericho Capital reports 7.2% stake in Core Scientific
Jericho Capital Asset Management L.P. and Josh Resnick report beneficial ownership of Core Scientific, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jericho Capital Asset Management L.P. and Josh Resnick report beneficial ownership of Core Scientific, Inc. common stock. They collectively hold 22,882,942 shares of common stock, representing 7.2% of the class.
Both reporting persons have shared voting power over 22,882,942 shares and shared dispositive power over 22,882,942 shares, with no sole voting or dispositive power. Jericho Capital Asset Management L.P. acts as investment adviser to certain investment funds and accounts that have the right to receive or direct dividends and sale proceeds from these shares. Josh Resnick is identified as a reporting person and managing member associated with the adviser. The reporting persons have entered into a joint filing agreement covering this ownership report.
Key Figures
Key Terms
beneficially owned financial
investment adviser financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of Core Scientific (CORZ) does Jericho Capital Asset Management L.P. own?
What is Josh Resnick’s reported ownership in Core Scientific (CORZ)?
Is there a joint reporting arrangement for the CORZ ownership disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.